Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic is a once-weekly GLP-1 receptor agonist injection, not a daily medication, which is one reason it became popular for type 2 diabetes and weight loss management. Semaglutide—the active ingredient in Ozempic—works by slowing digestion and increasing feelings of fullness, and its weekly schedule improves patient compliance compared to daily alternatives. PlexusDx provides access to compounded semaglutide injections that follow the same evidence-based dosing framework.

Ozempic Injection Frequency: Weekly Schedule Explained

Ozempic is administered as a once-weekly subcutaneous injection, meaning patients inject the medication under the skin one time each seven days. The standard dosing protocol begins at 0.25 mg weekly, with dose escalation occurring every four weeks as tolerated, up to a maximum of 2 mg weekly. This weekly frequency reduces the medication burden compared to daily pills or injections, which improves adherence rates in real-world studies.

The pharmacology of semaglutide supports weekly dosing because of its extended half-life of approximately seven days in the body. This long duration allows the medication to maintain therapeutic levels throughout the week, so patients do not need daily dosing to achieve consistent appetite suppression and metabolic effects. PlexusDx compounded semaglutide injections follow the same pharmacological principles and weekly injection schedule as branded Ozempic.

How Semaglutide Weekly Dosing Compares to Daily Alternatives

Oral semaglutide tablets (Rybelsus) require daily dosing on an empty stomach and must be taken 30 minutes before other medications or food, creating significant lifestyle restrictions. Injectable semaglutide, by contrast, needs only one injection per week regardless of meal timing, making it more flexible for busy schedules. Clinical trials show weekly injection adherence rates exceed 80 percent, while daily oral medications experience lower compliance due to complex timing requirements.

PlexusDx offers both compounded semaglutide injections (weekly schedule, $149/month) and oral semaglutide tablets (daily dosing, $249/month) so patients can choose the format that fits their lifestyle. The weekly injection format eliminates the need to remember daily doses and reduces the interaction risks associated with oral medications taken on an empty stomach.

Starting Dose and Titration Schedule for Weekly Semaglutide

Treatment begins with 0.25 mg injected once weekly for four weeks, allowing the body to adjust to the medication while minimizing nausea and gastrointestinal side effects. After the first month, the dose typically increases to 0.5 mg weekly if tolerated, then progresses through 1 mg, 1.5 mg, and up to 2 mg weekly based on individual response and tolerability. This gradual titration approach reduces the intensity of side effects and gives the body time to adapt to the appetite-suppressing effects.

PlexusDx provides personalized dose management guidance, and your dose may need to go up—your price won't. All semaglutide injection therapy remains flat at $149 per month across all three commitment tiers, regardless of whether patients are taking 0.25 mg or 2 mg weekly. This transparent pricing removes uncertainty and allows patients to focus on finding their optimal therapeutic dose without worrying about escalating costs.

Why Weekly Injections Improve Long-Term Weight Loss Outcomes

Once-weekly semaglutide injections produce superior weight loss outcomes compared to daily oral formulations in head-to-head trials, with some studies showing an average of 10-15 percent body weight reduction over 68 weeks of treatment. The consistent weekly dosing maintains stable blood levels of semaglutide, which optimizes appetite suppression throughout the week and reduces the likelihood of breakthrough hunger between doses. Higher adherence rates with weekly schedules also contribute to better sustained weight loss because patients are more likely to continue therapy as prescribed.

PlexusDx patients on compounded semaglutide injections gain access to the Precision Peptide Genetic Test (add-on, $99 after first month), which analyzes key genetic variants including GLP1R rs6923761 and FTO rs9939609 that predict individual responsiveness to semaglutide therapy. Understanding your genetic peptide pathways helps optimize whether semaglutide alone or combination therapy like GLP-Squared (semaglutide plus tirzepatide) will produce the best results for your unique metabolism.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Ozempic really a weekly injection, or do some people take it daily?

Ozempic is exclusively a once-weekly injection; there is no daily version of the branded product. Semaglutide is available in daily oral form (Rybelsus), but the injectable format is only dosed weekly due to its long half-life. PlexusDx compounded semaglutide injections follow the same weekly schedule and can be started immediately without insurance approval.

What clinical evidence supports weekly semaglutide over daily dosing?

The SUSTAIN clinical trial series showed that once-weekly semaglutide injections produced HbA1c reductions of 1.5-1.8 percent in type 2 diabetes patients, with weight loss averaging 3-6 kg over 30 weeks. Weekly injection adherence exceeds 80 percent in real-world settings, compared to 60-70 percent for daily oral medications, which translates to better sustained therapeutic outcomes. This evidence base supports why PlexusDx emphasizes the compounded weekly injection as the primary semaglutide delivery method.

How much does compounded semaglutide cost compared to branded Ozempic?

PlexusDx compounded semaglutide injections start at $149 per month with no insurance required, no membership fee, and HSA/FSA eligibility. This pricing remains flat across all three commitment tiers, meaning your dose can increase from 0.25 mg to 2 mg weekly without any change to your monthly cost. Branded Ozempic typically costs $900-1,500 per month through insurance or cash pay, making compounded semaglutide significantly more accessible.

Are there any side effects related to the weekly injection schedule?

The most common side effects—nausea, vomiting, and constipation—occur during the dose titration phase (first 4-8 weeks) and generally improve as the body adjusts. Weekly dosing allows for a slower titration schedule compared to daily medications, which actually reduces the intensity and duration of side effects in most patients. If side effects persist, PlexusDx clinical teams can adjust the titration pace or explore alternative compounds like tirzepatide, which has a different safety profile for some individuals.

Can the Precision Peptide Genetic Test predict if weekly semaglutide will work for me?

PlexusDx Precision Peptide Genetic Test analyzes your GLP1R rs6923761 variant and 49 other peptide-related genes across 14 metabolic pathways to predict semaglutide responsiveness and identify whether dual-compound therapy may be more effective. The test (add-on, $99 after first month of treatment) is not pharmacogenomic but rather peptide-pathway focused, providing insights into your natural appetite regulation and weight metabolism genetics.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves